跳至主要内容
临床试验/CTRI/2018/01/011157
CTRI/2018/01/011157已完成未知

A prospective comparative study of mifepristone followed by misoprostol or ethacridine lactate and oxytocin for second trimester abortions

Project in the Department of Obstetrics and Gynecology0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Second trimester abortions for medical, social, eugenic reasons
  • 2.Intrauterine pregnancy
  • 3.18-40 years
  • 4.Consent to participate in the study

排除标准

  • 1.Less than 13 weeks and more than 20 weeks pregnancy terminations
  • 2.Patients with history of renal disease or hepatic disease or bronchial asthma or hematological disease or glaucoma or heart disease etc
  • 3.Hemoglobin less than 10 gm/dl
  • 4.Patients with previous caesarean section and other uterine scars
  • 5.Symptomatic reproductive tract infections
  • 6.Hypersensitivity to mifepristone or misoprostol or ethacridine lactate or oxytocin
  • 7.Rupture of membranes

研究者

发起方
Project in the Department of Obstetrics and Gynecology

相似试验